The molecular characterization of an entire spectrum of slow-flow vascular malformations revealed the presence of well-known oncogenic driver mutations in PIK3CA that cause cancer in other tissues (111) and drive venous and lymphatic malformations in the endothelium (112–118). Here, PIK3CA is linked to cancer.